This compound is a spirocyclic compound containing both carboxylic acid and amide functional groups. It is primarily used as a pharmaceutical intermediate and is offered as a research chemical for laboratory and manufacturing applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1455358-16-3
Spiro[6H-cyclopenta[b]pyridine-6,3'-[3H]pyrrolo[2,3-b]pyridin]-2'(1'H)-one, 3-chloro-1'-(1,1-dimethylethyl)-5,7-dihydro-, (3'R)-
pharmaceutical intermediate
(6S)-1'-tert-butyl-3-chlorospiro[5,7-dihydrocyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-2'-one
research compound
4-Chloro-2-hydroxy-5-sulfamoylbenzoic acid
pharmaceutical intermediate
Ethyl 4-methylidenecyclohexane-1-carboxylate
pharmaceutical intermediate
3-((3aS,4R,6S,6aR)-6-(2-Hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-one
pharmaceutical intermediate
Afatinib Impurity J
pharmaceutical intermediate
(S)-2'-oxo-1',2',5,7-tetrahydrospiro(cyclopenta(b)pyridine-6,3'-pyrrolo(2,3-b)-bipyridine)-3-carboxylic acid
pharmaceutical intermediate
(6S)-1'-tert-butyl-2'-oxospiro[5,7-dihydrocyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic acid
SNCFRKKJQVCWMN-IBGZPJMESA-N
CC(C)(C)N1C2=C(C=CC=N2)[C@]3(C1=O)CC4=C(C3)N=CC(=C4)C(=O)O